Stay Informed on Key Developments

Investor News and Updates

Bill_Ipad

Stay informed about key developments at our company as they happen. Discover our Ad-Hoc Releases and subscribe to our newsletter to receive the latest news and topics of interest.

91 - 100of 392 News

91 - 100of 392 News

August 28, 2022

Not intended for U.S. and UK Media

Bayer initiates landmark Phase III study program to investigate oral FXIa inhibitor asundexian

August 12, 2022

Bayer statement on the decision in the BASF arbitration proceedings

August 11, 2022

Bayer Showcases Leadership in Breakthrough Innovations and Sustainable, Tailored Solutions to Meet Global Challenges in Agriculture

August 08, 2022

Not intended for U.S. and UK Media

U.S. FDA approves additional indication of darolutamide in combination with docetaxel for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC)

August 04, 2022

Second quarter of 2022

Bayer: Strong growth, outlook raised

August 01, 2022

Bayer expands existing investment to acquire majority share in sustainable lower carbon oilseed producer CoverCress Inc.

July 14, 2022

Bayer to sell men’s health product Nebido™ to Grünenthal

June 30, 2022

Not intended for U.S. and UK Media

Kerendia™ (finerenone) approved in China for the treatment of adults with chronic kidney disease associated with type 2 diabetes

June 29, 2022

Not intended for U.S. and UK Media

Bayer opens new Research & Innovation Center in Boston-Cambridge demonstrating its commitment to precision oncology

June 28, 2022

Not intended for U.S. and UK Media

Bayer expands Radiology Business into AI Market with Calantic™ Digital Solutions

Inform Yourself on Special Topics

Control Weeds Not Farming

Control Weeds, Not Farming

Farmers discussing their weed management

Everything You Need to Know About Glyphosate

some-bayer-group-headquarters

Managing Glyphosate Litigation

woman harvesting carrots

Managing and Mitigating PCB Litigation Risk